Silver Metal Complex as a Luminescent Probe for Enzymatic Sensing of Blood Plasma Glucose and Urine
In this work, we present a facile preparation of a paper-based glucose assay for rapid, sensitive, and quantitative measurement in blood plasma and urine. Two copper phosphorescent complexes [Cu(2,9-dimethyl-4,7-diphenyl-1,10-phenanthroline) (2,6- PPh2C6H4−PPh−C6H4PPh2 [bis(o-diphenylphosphinophenyl)phenylphosphine]) have been synthesized and their oxygen sensing abilities were investigated. The dimetallic phosphine-based Ag3 complex, having high oxygen sensing ability, was employed as an efficient signal transducer in enzymatic reactions to recognize blood plasma glucose and urine glucose, which provided a wide linear response for a concentration range between 1.0 and 35 mM and a rapid response, with a limit of detection (LOD) for glucose of 0.09 mM. In practical application, this Ag3 paper-based device offers great analytical reliability and accuracy upon monitoring glucose concentrations in blood plasma.
Introduction
Optical oxygen and glucose probes are appealing in food, industrial safety and health control. 1, 2 Optical sensors provide several promising features over electrochemical-based meters. They can detect analytes in matrices with minimal sample pretreatment, allow real-time continuous monitoring and provide important information about the biomolecular structures and environments associated with healthy and diseased states. Also they are free of electromagnetic disturbances. 3 Combining the optical probe with modern microelectronics and optoelectronics, such as mobile phones and fiber optics, offers powerful devices for sensing in several fields. 1, 4 Moreover, optical probes loaded on the cellulose paper to construct paper-based analytical tools have shown great potential in the development of point-of-care tests. 5 Glucose is one of the most popular analytes in the research field because abnormal levels of glucose are related to diabetes, a chronic metabolic disease influencing a great population of people worldwide. 6 GQDs, 11, 12 Ir-Zn e , 13 CdSe/ZnS, 14 and rhodamine derivatives. 15 For healthy humans, concentrations of glucose in the blood and urine of ca. 4.4-6.6 mM and 0.1-0.8 mM, respectively, are normally detected. 16 According to the American Diabetes Association, for diabetics, the blood glucose concentration should be maintained below 10 mM (180 mg/dl). 5 An optical glucose sensing system contains three main parts: (i) a recognition part: an element to selectively recognize an analyte in the matrix, (ii) a transducer part: an element that can convert the recognition signal from the probe into a measurable signal, and (iii) a signal processing part: a system that converts the signal into a readable format. 17 A number of aspects concerning these three parts need to be considered in order to optimize the development of biosensors, including easy for preparation and use, provision of fast response, accuracy, sensitivity and selectivity and simultaneously the miniaturization of the instruments. show diverse coordination behavior with respect to a wide range of ionic and neutral ligands to give numerous materials, which exhibit intriguing thermo-, vapo-, and mechanochromic luminescence. [18] [19] [20] [21] [22] [23] [24] [25] In this contribution, we present the comparative analysis of two copper phosphorescent complexes Cu1, Cu2 and a novel silver congener Ag3 (Chart 1) for the purpose of sensing molecular oxygen, blood plasma glucose and urine. From the viewpoint of sensitivity and stability, the dimetallic phosphinebased Ag3 complex is successfully employed as an efficient transducer in enzymatic reactions to recognize glucose in blood plasma and urine. The success of this proof-of-concept relies on the high oxygen sensing ability of Ag3, even in the form of an amorphous phase, which offers the advantages of simplifying the overall preparation of a glucose assay, and a wide range of glucose concentrations to be monitored (1.0-35 mM). This system has proven to possess higher sensitivity and better selectivity than previously reported works. Detail of results and discussion is elaborated as follows. 
Chemical and reagents
Glucose oxidase (GOx, EC 1.1.3.4 from Aspergillus Niger) with a specific activity of 1 529 80 U g -1 of lyophilized solid, D-(+)-
and lauric acid (≧99%) were purchased from Sigma-Aldrich. Sodium chloride (99.8%) and calcium chloride dehydrate (≧ 99%) were obtained from J.T. Baker. Sodium fluoride (NaF, 99%) and ethylenediaminetetraacetic acid (EDTA, 98% ~ 110%) were purchased from Alfa aesar and Riedel-deHaën, respectively. All of the chemicals were used without further purification.
The measurement of oxygen collision efficiency
The oxygen collision efficiencies of Cu1, Cu2 and Ag3 on paper were evaluated based on the principle of luminescence intensity quenching. The Cu1, Cu2 and Ag3 in methanol solution (10 -3 M) were dropped on the filter papers, which The O 2 concentrations were accurate to 0.1%. The output flow rate of the gas mixture was maintained at 500 mL min −1 .
Device fabrication
Filter paper treated with solution of Ag3 was cut into circles of 0.5 cm diameter and placed on cell dishes. Subsequently, 40 mg sodium alginate was dissolved in 1 mL of water and then the solution was mixed with glucose oxidase in phosphate buffer solution (1 mL). The resulting solution (10 μL) was then dropped into the cell dish, and 0.2 M calcium chloride solution (10 μL) was added to the dish to form the hydrogel. 10 μL of glucose standard solution, blood plasma sample or urine was spotted onto the hydrogel, and the phosphorescence emission under irradiation at 405 nm was measured with a fiber-optic system.
Preparation of glucose solution, serum, blood and urine samples
Various concentrations of glucose solution ranging from 0.01 to 50 mM were dissolved in phosphate buffer (pH 7.0).
Phosphate buffer was prepared from monosodium phosphate monohydrate and disodium hydrogen phosphate (Merck). Human serum (SRM 965b) was purchased from NIST, and the glucose concentration (16 mM) in the serum was certified by isotope dilution gas chromatography mass-spectrometry. 27 The serum solutions were filtered by using the Nanosep centrifugal device with a cut-off of 3 kDa at 14,000 rpm and 4°C for 10 min to remove protein. 28 The collection and analysis of blood and urine samples was approved by the institutional review board of Taipei Veterans General Hospital (Taiwan; IRB registration number 2017-12-002CC). Blood sampling was performed with a disposable lancet, and samples were collected into anticoagulants (EDTA 1.8 g/L and NaF 3g/L). The blood plasma were collected from the upper layer containing plasma water and protein, which were then analyzed in triplicate. A mid-stream specimen of urine was collected without any further treatments. Next, glucose concentrations in buffer solution ranging from 1 to 20 mM were added to the urine sample.
Sensing detection of glucose, and analysis of glucose sensing efficiency
The luminescence detection of glucose was carried out with a bifurcated optical fiber system (QBIF600-UV-VIS, Ocean Optics) and optical data were collected using a CCD image sensor (QE65000, Ocean Optics). 10 µL of different concentrations of glucose in phosphate buffer, blood plasma or urine were respectively added into the dishes. A 405 nm LED (LLS-405, Ocean Optics) was used as the excitation source, coupled with an edge filter having a cut-off wavelength of 455 nm throughout the measurement. The fiber-optic data were collected every 200 ms for 30 s. Finally, the change in luminescence intensity and the corresponding kinetic behaviour were recorded. The kinetic behaviour and efficiency of the Ag3 paperbased glucose sensor, i.e., the phosphorescence change rate, were evaluated by equation (1), where I t is the phosphorescence intensity at time t, I 0 and I 1 are the phosphorescence intensities at the beginning and on reaching saturation, respectively, and the point of inflection in the curve (t max ) and dt signifies the time for most significant phosphorescence changes in intensity. was synthesized from its BF 4 -precursor 21 via straightforward counterion exchange using commercially available Na(tfpb) salt. The choice of the bulky anion tfpb -is dictated by the need to ensure uniformity, low density and appreciable porosity of the noncrystalline solids, which are formed on the paper support.
Molecular gas oxygen quenching ability of Cu1, Cu2 and Ag3
The relevant crystalline Cu(I) complexes have been shown to possess good gas oxygen sensing ability in neat microcrystalline forms. 21, 26, 29 This property was attributed to the presence of sufficient void space within the solid to allow oxygen molecules to penetrate into the bulk material and result in quenching of the excited triplet excited state of the complex by the ground state triplet oxygen via collisional interactions in the confined space. 21, 26, 29 For choosing the most suitable materials among readily available Cu1, Cu2 and Ag3 for the further glucose sensing test, we first determined the Stern-Volmer quenching constants (K SV ) between complexes and oxygen on paper, i.e., oxygen quenching ability. As shown in Figure 1(a)-(c) , at 1 atm of O 2 at room temperature, the emission intensities of Cu1, Cu2 and Ag3 were quenched by 80.88%, 79.40%, and 96.50%, respectively. The results revealed that the oxygen sensing property of Ag3 was better than those of Cu1 and Cu2. The ratios between peak intensity of the absence of oxygen (I 0 ) and the exposure of different concentrations of O 2 (I) against the mole fraction of O 2 in nitrogen were not linear (Figure 1(d)-(f) ). Accordingly, the data were fitted by a two-site model, which is described by equation (2):
where f 1 and f 2 denote the fractions of the total emission intensity generated by each site, and K SV1 and K SV2 are the Stern-Volmer quenching constants for the two sites. Pertinent fitting data are summarized in Table 1 ) was higher than that of Pd-porphyrin complexes-doped and the nanosilver containing Ru(bipy) 3
2+
in ethylcellulose with silver nanoparticles, but lower than the value recently reported for a silver-chalcogenolate cluster-based metal-organic framework. [30] [31] [32] The sensitivity of Cu2, which has been previously studied in crystalline form to reach a high K SV value of 96 atm -1 and a linear Stern-Volmer relationship, 26 on paper demonstrated a substantial decrease (max K SV1 = 22.7 atm -1 ), essentially due to the noncrystalline nature of the film, which was expected to give a lower effective quenching area. The minimum detectable concentrations (LODs) of oxygen for Cu1, Cu2 and Ag3 were calculated to be 0.32%, 0.39%, and 0.08%, respectively, from three times the signal to noise ratio. Taking advantage of a large K SV value and its excellent stability, compound Ag3 was employed as a paradigm for the following glucose-sensing experiments.
Design of paper-based glucose sensor
In this design, in order to fulfil the criteria of higher sensitivity and better stability than those of the electrochemical-type glucose biosensor, compound Ag3 was chosen as the main sensing molecular material to recognize glucose. Furthermore, the large quenching constant of Ag3 offers several advantages such as simplifying the fabrication of a glucose assay device (vide infra), expansion of the glucose response range and better selectivity toward glucose. As illustrated in Figure 2 , a methanol solution of Ag3 was added into the paper, which was placed on the cell dishes and then capped with enzyme hydrogel. Also, for the control test, GOx was deposited on air onto Ag3 directly without mixing with hydrogel (see Figure S1 in the supporting information). When 20 mM of glucose was added to this device without hydrogel, the change in emission intensity gradually decreased, suggesting that the emission was quenched by glucose. On the contrary, when 20 mM of glucose was added to the hydrogel-capped Ag3 on paper, the change in emission intensity gradually elevated. Therefore, when human blood glucose or urine was added to the dishes, oxygen molecules in the interior of the biosensor were consumed by GOx. As a result, upon photoexcitation of the sample with diode laser or blue OLED with suitable wavelength, the enhanced emission intensity of the Ag3 complex was recorded and analyzed.
Optimization of the amount of sodium alginate, the effect of the concentration and pH of buffer, and the concentration of GOx
The amount of sodium alginate and gelling agent, e.g., calcium chloride, in a biosensor device should affect the degree of crosslinking and the pore size of the hydrogel. 33 Therefore, various
concentrations of sodium alginate were tested to achieve the optimized emission change rate upon the addition of 20 mM glucose with 15 mg mL-1 GOx in 100 mM PBS buffer solution (pH = 7) and a fixed gelling agent concentration of 0.2 M (10 μL). The maximum emission change rate was calculated according to eqn (1) . It was found that the amount of sodium alginate of 40 mg in 1 mL buffer distinctly facilitated the emission change rate in the reaction with glucose, as shown in Figure 3(a) . The effects of the concentration and pH value of the buffer on the relative change rates of the immobilized GOx are compared in Figure 3 (b) and 3(c). The influences of pH value of the buffer solution in the pH range of 5.0-9.0 upon addition of 20 mM glucose with 15 mg mL-1 GOx in 100 mM PBS solution was studied. As can been seen from Figure 3(b) , the maximum change rate of phosphorescence increased with the elevation of pH value and reached its maximum at 7.0. This value is slightly more acidic than free GOx in PBS solution, 34 indicating that the enzyme activity shifts resulted in the maximum emission change rate. Accordingly, 20 mg mL-1 GOx in 10 mM buffer solution of pH 7.0 was used in further calibration curve construction and real sample analyses.
Paper-based biosensor for glucose sensing
On the basis of the above optimized conditions, a calibration curve of glucose analysis was constructed. As shown in Figure 4 (a), the intensity of the characteristic peak at 530 nm and response curve increased when the concentration of glucose increased, and the response time (i.e., oxygen exhausting) was less than 10 s, which represents a fast response as compared with other optical glucose sensors (Table 2) . [glucose] + 124.9, with an R 2 value of 0.9972; for N = 3). The detection limit was 0.09 mM from three times the signal-to-noise ratio. It has been noted above that this glucose concentration range is suitable for diagnosis of both normal persons (4.4-6.6 mM in blood; 0.1-0.8 mM in urine) and diabetes patients. Comparing with majority of other optical glucose sensing systems reported previously (see Table 2 ), the proposed method provides a wider sensing range, faster response, and good sensitivity. Additionally, the Michaelis-Menten constant (K m ) of GOx in hydrogel was calculated by using a Lineweaver−Burke plot with glucose concentrations in the range of 3-35 mM. The K m value was calculated to be 17.43 mM (Figure S2 ), which was much lower than the reported value of 33 mM of free GOx. 45 This apparently indicates that the binding affinity of the glucose was improved when the GOx was confined in hydrogel, as compared with that of free GOx in solution.
Selectivity of glucose detection
For the application of glucose detection in blood (plasma and serum) and urine, competitive molecules and/or ions in blood or urine, including D-fructose, maltose monohydrate and many others, which are listed in Table 3 , are considered on the relative emission intensities of the sensing system. Their normal ranges in humans for each corresponding substances are also listed in Table 3 . In this selectivity test of glucose, the concentrations of the potential interfering substances in blood (and urine) were prepared at ~10-fold (~100-fold) excess concentrations, higher than the typical normal levels in human blood and urine. The concentration of human serum albumin was 0.075 mM (saturated concentration). As shown in Figures 5(a) and 5(b) , all the substances, even in mixtures Please do not adjust margins
Please do not adjust margins of all agents interfere insignificantly with glucose determination in blood and urine. Therefore, the potential interfering substances in blood and urine could not effectively compete with glucose.
Glucose determination in human blood plasma and urine
For the performance of the proposed sensing system in practice, paper-based Ag3 was tested in serum first. Serum is the liquid part of blood plasma without the clotting factors, e.g. fibrinogen. The certified glucose concentrations of NIST SRM965b and their uncertainty were 16.35 ± 0.20 mM (Table 4) ; those obtained with the proposed method were 16.40 ± 0.203 mM with R.S.D values lower than 1.24%, which indicates that the results were accurate and that the proposed method can assay intrinsic glucose molecules in serum. Next, the applicability of the proposed system for human biofluids was proven by analysing glucose in human blood plasma and urine. To prevent blood clotting, human blood was collected into anticoagulants; then blood plasma were collected before assay. The measured glucose levels was found to be 6.24 ± 0.04 mM, which is in accordance with the values from the glucometer (Roche, Accu-Chek Active), indicating that the present method has negligible interference from the protein. Urine samples were used directly without any pre-treatment. Glucose in human blood plasma and urine was determined by the standard addition method. As shown in Table 4 , the measured values of the four samples in blood plasma and urine were respectively 3.056 ± 0. 
Stability
Last but not least, the storage stability of this biosensor was examined during storage at 4 o C and measured for a period of 45 days. Results are shown in Figure S3 . The samples were tested upon addition of 20 mM glucose, and the biosensor retained 97.78% of its initial response rate during the first 15 days. After 45 days, the paper-based samples still retained 99.75% of the initial response rate, showing excellent storage stability for the practical application.
Conclusions
Compounds Cu1, Cu2, and Ag3 were synthesized and their oxygen-quenching abilities examined with various comparative analyses. As a result, a facile overall preparation of a paperbased glucose assay is described in this paper. This achievement was attained through the incorporation of the Ag3 complex, which has high oxygen sensing ability and stability on paper, ensuring a more effective collision with oxygen and resulting in a wide sensing range for recognizing glucose. Moreover, this paper-based device is cost effective and provides a fast response time (10 s) for sensing glucose in a quantitative manner. The performance of the present device is superior to those of other optical glucose sensors. Furthermore, the paper-based device provides a stronger binding affinity to glucose, resulting in high specificity. The improvements in this device allow the detection of glucose in human blood and urine in high precision and reliability.
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